Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Rizzetto

Showing results (181-190 of 198) with videos related to

Pageof 20
Sort By:
Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 18, 2024
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International NetworkAnika Wranke, Cirley Lobato, Emanoil Ceausu, et al.
Inflammatory Bowel Diseases|January 9, 2007
Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's diseaseFrancesca Bresso, Johan Askling, Marco Astegiano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 3, 2014
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug AgencyFloriano Rosina, Maria Elena Tosti, Elisabetta Borghesio, et al.
Journal of the National Cancer Institute|March 3, 2005
Randomized trial of different screening strategies for colorectal cancer: patient response and detection ratesNereo Segnan, Carlo Senore, Bruno Andreoni, et al.
Annals of Hepatology|April 21, 2017
Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin PretransplantEric M Yoshida, Paul Kwo, Kosh Agarwal, et al.
Health Science Reports|April 3, 2019
Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II)Tarik Asselah, Negar Niki Alami, Christophe Moreno, et al.
Annals of Internal Medicine|June 9, 2005
Digestive endoscopy is not a major risk factor for transmitting hepatitis C virusAlessia Ciancio, Paola Manzini, Franco Castagno, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 16, 2023
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver TransplantationPaolo Angelo Cortesi, Raffaella Viganò, Sara Conti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2011
Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian WorkshopGiampiero Carosi, Mario Rizzetto, Alfredo Alberti, et al.
Pageof 20

Showing results (181-190 of 198) with videos related to

Sort By:
Pageof 20
Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 18, 2024
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International NetworkAnika Wranke, Cirley Lobato, Emanoil Ceausu, et al.
Inflammatory Bowel Diseases|January 9, 2007
Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's diseaseFrancesca Bresso, Johan Askling, Marco Astegiano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 3, 2014
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug AgencyFloriano Rosina, Maria Elena Tosti, Elisabetta Borghesio, et al.
Journal of the National Cancer Institute|March 3, 2005
Randomized trial of different screening strategies for colorectal cancer: patient response and detection ratesNereo Segnan, Carlo Senore, Bruno Andreoni, et al.
Annals of Hepatology|April 21, 2017
Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin PretransplantEric M Yoshida, Paul Kwo, Kosh Agarwal, et al.
Health Science Reports|April 3, 2019
Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II)Tarik Asselah, Negar Niki Alami, Christophe Moreno, et al.
Annals of Internal Medicine|June 9, 2005
Digestive endoscopy is not a major risk factor for transmitting hepatitis C virusAlessia Ciancio, Paola Manzini, Franco Castagno, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 16, 2023
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver TransplantationPaolo Angelo Cortesi, Raffaella Viganò, Sara Conti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2011
Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian WorkshopGiampiero Carosi, Mario Rizzetto, Alfredo Alberti, et al.
Pageof 20